The objective of this study is to determine if there is an increased risk of cancer with pantoprazole (Protonix®), relative to other proton pump inhibitors.
Investigator: Corley, Douglas
Funder: Wyeth-Lederle S.p.A.
Explore all studies and publications
Division of Research
Oakland, CA 94612
Follow us on these external social media sites that will open in a new browser window.
© 2023 Kaiser Permanente Division of Research